Incentives and barriers to retinopathy screening among African-Americans with diabetes

Journal of Diabetes and its Complications

Volumn 11, Issue 5, 1997, Pages 298-306

  Walker, Elizabeth A ^a,b   Basch, Charles E ^b   Howard, Crystal J ^b   Zybert, Patricia A ^b   Kromholz, W Noah ^c   Shamoon, Harry ^a  

^a NASSAU UNIVERSITY MEDICAL CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; DIABETES MELLITUS; DIABETIC RETINOPATHY; ECONOMIC ASPECT; EYE FUNDUS; FEAR; FEMALE; HEALTH PROMOTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTIVATION; NEGRO; PRIORITY JOURNAL; SCREENING;

ADULT; AFRICAN AMERICANS; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DIABETIC RETINOPATHY; FEAR; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTERVIEWS; MALE; MASS SCREENING; MIDDLE AGED; MOTIVATION; NEW YORK; TELEPHONE;

EID: 0030876152     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(96)00121-3     Document Type: Article

References (28)

1. Klein R, Klein BEK: Vision disorders in diabetes, in Harris, MI, Diabetes in America, 2nd edition. Bethesda, MD: National Institutes of Health (NIH) publication no. 95-1468, 1995, pp. 293-338.
2. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102:520-526, 1984.
3. Singer DE, Nathan DM, Fogel HA, Schachat AP: Screening for diabetic retinopathy. Ann Intern Med 116:660-671, 1992.
4. American Diabetes Association: Screening for diabetic retinopathy: Position statement. Diabetes Care 19:520-522, 1996.
5. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. III. Prevalence and risk of diabetic retinopathy when age as diagnosis is 30 or more years. Arch Ophthalmol 102:527-532, 1984.
6. Early Treatment Diabetic Retinopathy Study Research Group: Photocoagulation for diabetic macular edema. Arch Ophthalmol 103:1796-1806, 1985.
7. Klein R, Klein BEK, Moss SE: Visual impairment in diabetes. Ophthalmology 91:1-9, 1984.
8. Klein BEK, Klein R, Jensen SC: Open angle glaucoma and older onset diabetes. The Beaver Dam Eye Study. Ophthalmology 101:1173-1177, 1994.
9. Arfken C, Salicrup AE, Meuer SM, Del Priore LV, Klein R, McGill JB, Rucker CS, White NH, Santiago JV: Retinopathy in African American and Whites with insulin-dependent diabetes mellitus. Arch Intern Med 154:2597-2602, 1994.
10. Appiah AP, Ganthier R, Watkins N: Delayed diagnosis of diabetic retinopathy in Black and Hispanic patients with diabetes mellitus. Ann Ophthalmol 23:156-158, 1990.
11. Blendon RJ, Aiken LH, Freeman HE, Corey CR: Access to medical care for black and white Americans. JAMA 261:278-281, 1989.
12. Cowie CC, Harris MI, Silverman RE, Johnson EW, Rust KF: Effect of multiple risk factors on differences between Blacks and Whites in the prevalence of non-insulin-dependent diabetes mellitus in the United States. Am J Epidemiol 137:719-732, 1993.
13. Harris EL, Feldman S, Robinson CR, Sherman S, Georgopoulos A: Racial differences in the relationship between blood pressure and risk of retinopathy among individuals with NIDDM. Diabetes Care 15:748-754, 1992.
14. Rabb MF, Gagliano DA, Sweeney HE: Diabetic retinopathy in blacks. Diabetes Care 13(suppl 4):1202-1206,1990.
15. Diabetic Retinopathy Study Research Group. Report 3: Four risk factors for severe vision loss in diabetic retinopathy. Arch Ophthalmol 97:654-655, 1979.
16. American College of Physicians, American Diabetes Association, American College of Ophthalmology: Screening guidelines for diabetic retinopathy. Ann Intern Med 116:683-685, 1992.
17. Witkin SR, Klein R, Jensen SC: Ophthalmologic care for people with diabetes. JAMA 251:2531-2534, 1984.
18. Brechner RJ, Cowie CC, Howie J, Herman WH, Will JC, Harris MI: Ophthalmic examination among adults with diagnosed diabetes mellitus. JAMA 270:1714-1718, 1993.
19. Will JC, German RR, Schurman E, Michael S, Kurth DM, Deeb L: Patient adherence to guidelines for diabetic eye care: Results from the Diabetic Eye Disease Follow-Up Study. Am J Public Health 84:1669-1671, 1994.
20. Wylie-Rosett J, Basch C, Walker EA, Zybert P, Shamoon H, Engel S, Cypress C: Ophthalmic referral rates for patients with diabetes in primary-care clinics located in disadvantaged urban communities. J Diabet Complications 9:49-54, 1995.
21. Green LW, Kreuter MW: Health Promotion Planning: An Educational and Environmental Approach. Mountain View, CA: Mayfield, 1991.
22. Daniel M, Green LW: Application of the Precede-Proceed Model in diabetes prevention and control: A case illustration from a Canadian Aboriginal community. Diabetes Spectrum 8:74-84, 1995.
23. Moss SE, Klein R, Klein BEK: Factors associated with having eye examinations in persons with diabetes. Arch Fam Med 4:529-534, 1995.
24. The DCCT Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993.
25. Javitt JC, Aiello LP, Chiang Y, Ferris FL, Canner JK, Greenfield S: Preventive eye care in people with diabetes is cost-saving to the federal government. Diabetes Care 17:909-917, 1994.
26. Dasbach EJ, Fryback DG, Newcomb PA, Klein R, Klein BEK: Cost-effectiveness strategies for detecting diabetic retinopathy. Med Care 29:20-39, 1991.
27. Airhihenbuwa CO: Health promotion and disease prevention strategies for African Americans: A conceptual model, in Braithwaite RL, Taylor SE, (eds), Health Issues in the Black Community. San Francisco, CA: Jossey-Bass, 1992, pp. 267-280.
28. Fisher EB, Heins JM, Hiss RG, Lorenz RA, Marrero DG, McNabb WL, Wylie-Rosett J: Metabolic Control Matters: Nationwide Translation of the Diabetes Control and Complications Trial. Bethesda, MD; National Diabetes Information Clearinghouse (PHS Document 94-377), 1994.